Roche and Chugai Pharma report positive Phase III results of haemophilia A drug

Roche and UK-based Chugai Pharmaceutical have reported positive data from the Phase III HAVEN 1 clinical trial of emicizumab in patients suffering from haemophilia A.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news